LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Trametinib | 3.33 | uM | LJP5 | 2 | P20 | 72 | hr | 1311 | 1767 | 5100 | 0.3465 | 0.1643 |
MDA-MB-231 | Trametinib | 3.33 | uM | LJP5 | 3 | P20 | 72 | hr | 1311 | 1795 | 5010 | 0.3582 | 0.1761 |
MDA-MB-231 | Trametinib | 10 | uM | LJP5 | 1 | P19 | 72 | hr | 1311 | 1759 | 5128 | 0.3430 | 0.1609 |
MDA-MB-231 | Trametinib | 10 | uM | LJP5 | 2 | P19 | 72 | hr | 1311 | 1636 | 5100 | 0.3208 | 0.1194 |
MDA-MB-231 | Trametinib | 10 | uM | LJP5 | 3 | P19 | 72 | hr | 1311 | 1655 | 5010 | 0.3303 | 0.1278 |
MDA-MB-231 | Omipalisib | 0.04 | uM | LJP6 | 1 | N06 | 72 | hr | 1311 | 3100 | 4870 | 0.6365 | 0.5753 |
MDA-MB-231 | Omipalisib | 0.04 | uM | LJP6 | 2 | N06 | 72 | hr | 1311 | 2907 | 4961 | 0.5859 | 0.5138 |
MDA-MB-231 | Omipalisib | 0.04 | uM | LJP6 | 3 | N06 | 72 | hr | 1311 | 3136 | 4973 | 0.6305 | 0.5735 |
MDA-MB-231 | Omipalisib | 0.12 | uM | LJP6 | 1 | N05 | 72 | hr | 1311 | 2282 | 4870 | 0.4686 | 0.3399 |
MDA-MB-231 | Omipalisib | 0.12 | uM | LJP6 | 2 | N05 | 72 | hr | 1311 | 2239 | 4961 | 0.4513 | 0.3213 |
MDA-MB-231 | Omipalisib | 0.12 | uM | LJP6 | 3 | N05 | 72 | hr | 1311 | 2175 | 4973 | 0.4373 | 0.3008 |
MDA-MB-231 | Omipalisib | 0.37 | uM | LJP6 | 1 | N04 | 72 | hr | 1311 | 1417 | 4870 | 0.2910 | 0.0416 |
MDA-MB-231 | Omipalisib | 0.37 | uM | LJP6 | 2 | N04 | 72 | hr | 1311 | 1654 | 4961 | 0.3334 | 0.1284 |
MDA-MB-231 | Omipalisib | 0.37 | uM | LJP6 | 3 | N04 | 72 | hr | 1311 | 1513 | 4973 | 0.3042 | 0.0771 |
MDA-MB-231 | Omipalisib | 1.11 | uM | LJP6 | 1 | N03 | 72 | hr | 1311 | 1225 | 4870 | 0.2515 | -0.0355 |
MDA-MB-231 | Omipalisib | 1.11 | uM | LJP6 | 2 | N03 | 72 | hr | 1311 | 1089 | 4961 | 0.2195 | -0.0924 |
MDA-MB-231 | Omipalisib | 1.11 | uM | LJP6 | 3 | N03 | 72 | hr | 1311 | 1058 | 4973 | 0.2127 | -0.1058 |
MDA-MB-231 | Omipalisib | 3.33 | uM | LJP6 | 1 | N02 | 72 | hr | 1311 | 921 | 4870 | 0.1891 | -0.1704 |
MDA-MB-231 | Omipalisib | 3.33 | uM | LJP6 | 2 | N02 | 72 | hr | 1311 | 810 | 4961 | 0.1633 | -0.2221 |
MDA-MB-231 | Omipalisib | 3.33 | uM | LJP6 | 3 | N02 | 72 | hr | 1311 | 933 | 4973 | 0.1876 | -0.1624 |
MDA-MB-231 | Omipalisib | 10 | uM | LJP6 | 1 | N01 | 72 | hr | 1311 | 650 | 4870 | 0.1335 | -0.3100 |
MDA-MB-231 | Omipalisib | 10 | uM | LJP6 | 2 | N01 | 72 | hr | 1311 | 581 | 4961 | 0.1171 | -0.3458 |
MDA-MB-231 | Omipalisib | 10 | uM | LJP6 | 3 | N01 | 72 | hr | 1311 | 649 | 4973 | 0.1305 | -0.3065 |
MDA-MB-231 | Buparlisib | 0.04 | uM | LJP5 | 1 | H06 | 72 | hr | 1311 | 5345 | 5128 | 1.0422 | 1.0425 |
MDA-MB-231 | Buparlisib | 0.04 | uM | LJP5 | 2 | H06 | 72 | hr | 1311 | 5053 | 5100 | 0.9908 | 0.9906 |